ATE495441T1 - Verfahren zum testen endokriner substanz in proben - Google Patents
Verfahren zum testen endokriner substanz in probenInfo
- Publication number
- ATE495441T1 ATE495441T1 AT05809384T AT05809384T ATE495441T1 AT E495441 T1 ATE495441 T1 AT E495441T1 AT 05809384 T AT05809384 T AT 05809384T AT 05809384 T AT05809384 T AT 05809384T AT E495441 T1 ATE495441 T1 AT E495441T1
- Authority
- AT
- Austria
- Prior art keywords
- analyte
- endocrine substance
- present
- endocrine
- measuring
- Prior art date
Links
- 230000002124 endocrine Effects 0.000 title abstract 8
- 239000000126 substance Substances 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- 239000012491 analyte Substances 0.000 abstract 7
- 241000282324 Felis Species 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 238000005259 measurement Methods 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Diabetes (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005190003A JP4197180B2 (ja) | 2005-06-29 | 2005-06-29 | 検体中の内分泌物質測定方法 |
| PCT/JP2005/021443 WO2007000832A1 (ja) | 2005-06-29 | 2005-11-22 | 検体中の内分泌物質測定方法。 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE495441T1 true ATE495441T1 (de) | 2011-01-15 |
Family
ID=37595091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05809384T ATE495441T1 (de) | 2005-06-29 | 2005-11-22 | Verfahren zum testen endokriner substanz in proben |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8058011B2 (de) |
| EP (1) | EP1898215B1 (de) |
| JP (1) | JP4197180B2 (de) |
| AT (1) | ATE495441T1 (de) |
| DE (1) | DE602005025940D1 (de) |
| WO (1) | WO2007000832A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5413766B2 (ja) * | 2008-03-10 | 2014-02-12 | 株式会社シバヤギ | レプチン測定方法 |
| US20110136141A1 (en) * | 2009-12-03 | 2011-06-09 | Abbott Laboratories | Peptide reagents and method for inhibiting autoantibody antigen binding |
| JP5504945B2 (ja) * | 2010-02-12 | 2014-05-28 | 日東紡績株式会社 | Ｆｔｃｄとその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法 |
| JP6835835B2 (ja) * | 2015-10-15 | 2021-02-24 | バイオコン・リミテッドＢｉｏｃｏｎ Ｌｉｍｉｔｅｄ | ヒト血清中の組み換えヒトインシュリンに対する中和抗体を検出するための方法 |
| CN117054645A (zh) * | 2016-09-06 | 2023-11-14 | 富士瑞必欧株式会社 | 甲状腺球蛋白的测定方法及测定试剂 |
| CN109564214A (zh) * | 2016-09-13 | 2019-04-02 | 富士瑞必欧株式会社 | 心肌肌钙蛋白的测定方法及测定试剂 |
| JP7138627B2 (ja) * | 2017-05-17 | 2022-09-16 | 富士レビオ株式会社 | インスリンの測定方法及び測定試薬 |
| JP7376007B2 (ja) * | 2017-06-02 | 2023-11-08 | 株式会社Ｌｓｉメディエンス | 生体試料中からの標的タンパク質の抽出方法および標的タンパク質の分析方法 |
| CN113631924A (zh) * | 2019-05-24 | 2021-11-09 | 富士瑞必欧株式会社 | 甲状腺球蛋白的测定方法和测定试剂 |
| CN111077323A (zh) * | 2020-01-12 | 2020-04-28 | 天津市宝坻区人民医院 | 消除胰岛素自身抗体干扰的胰岛素测定试剂盒 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855242A (en) * | 1986-04-14 | 1989-08-08 | Joslin Diabetes Center, Inc. | Method of detecting antibodies |
| JPH0291572A (ja) * | 1988-09-08 | 1990-03-30 | Nippon Dpc Corp | ウァルスｄｎａを用いた生物学的液体中の抗ｄｎａ抗体価の測定法および測定用キット |
| JPH03134567A (ja) * | 1989-10-19 | 1991-06-07 | Yamasa Shoyu Co Ltd | 抗リン脂質抗体結合用担体、それを使用する免疫学的測定法およびキット |
| JP2789306B2 (ja) * | 1994-11-15 | 1998-08-20 | 株式会社第一ラジオアイソトープ研究所 | インスリン様成長因子の免疫学的測定方法ならびにインスリン様成長因子測定用キット |
| JPH11326322A (ja) | 1998-05-06 | 1999-11-26 | Shibayagi:Kk | イヌインスリン測定用キットおよびそれを用いたイヌインスリン測定方法 |
| JP3740898B2 (ja) * | 1998-07-31 | 2006-02-01 | 三菱化学株式会社 | 生理活性成分の測定法 |
| WO2000007021A1 (en) * | 1998-07-31 | 2000-02-10 | Mitsubishi Chemical Corporation | Method for assaying physiologically active component |
| WO2003016575A1 (en) * | 2001-08-17 | 2003-02-27 | Luminex Corporation | Method for characterizing autoimmune disorders |
| US20050026826A1 (en) * | 2003-01-17 | 2005-02-03 | Margarethe Hoenig | Feline proinsulin, insulin and constituent peptides |
-
2005
- 2005-06-29 JP JP2005190003A patent/JP4197180B2/ja not_active Expired - Fee Related
- 2005-11-22 WO PCT/JP2005/021443 patent/WO2007000832A1/ja not_active Ceased
- 2005-11-22 US US11/988,063 patent/US8058011B2/en not_active Expired - Fee Related
- 2005-11-22 EP EP05809384A patent/EP1898215B1/de not_active Expired - Lifetime
- 2005-11-22 AT AT05809384T patent/ATE495441T1/de not_active IP Right Cessation
- 2005-11-22 DE DE602005025940T patent/DE602005025940D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007000832A1 (ja) | 2007-01-04 |
| EP1898215A4 (de) | 2008-11-05 |
| US20090176252A1 (en) | 2009-07-09 |
| DE602005025940D1 (de) | 2011-02-24 |
| EP1898215B1 (de) | 2011-01-12 |
| EP1898215A1 (de) | 2008-03-12 |
| JP2007010418A (ja) | 2007-01-18 |
| JP4197180B2 (ja) | 2008-12-17 |
| US8058011B2 (en) | 2011-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054851A1 (es) | Amperometria regulada | |
| BRPI0814201A2 (pt) | Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador | |
| DK2082239T3 (da) | Sekventiel analyse af biologiske prøver med intermediær blegning af fluorescerensdetektor | |
| ATE520026T1 (de) | Sequenzielle analyse biologischer proben | |
| WO2006026020A3 (en) | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin | |
| ATE414166T1 (de) | Glukosebiosensor und verfahren | |
| CL2011002228A1 (es) | Aparato para el analisis integrado de acidos nucleicos en tiempo real, y metodo de detecicion de dichas moleculas. | |
| BR112014016313A8 (pt) | medições precisas de analito para tira de teste eletroquímico com base em característica(s) física(s) detectada(s) da amostra contendo o analito e parâmetros de biossensores derivados | |
| BRPI0917839A2 (pt) | dispositivo de teste de diagnóstico portátil de uso único, e um sistema associado e método para teste de amostras de teste ambientais e biológicas | |
| WO2007136980A3 (en) | Diagnostic test media and methods for the manufacture thereof | |
| ATE541216T1 (de) | Fluoreszenztestverfahren | |
| BR0317394A (pt) | Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal | |
| BR112022011676A2 (pt) | Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método | |
| EP2573192A4 (de) | Verfahren und kit zur diagnose aim-vermittelter erkrankungen | |
| ATE495441T1 (de) | Verfahren zum testen endokriner substanz in proben | |
| WO2005124356A3 (en) | Use of protein cbp2 as a marker for colorectal cancer | |
| DE602006013333D1 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
| DE602007006671D1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| EP2012116A4 (de) | Verfahren und vorrichtung zur individuellen unterscheidung | |
| ATE511636T1 (de) | Verfahren zum nachweis biologischer organismen mittels raman-streuung | |
| WO2006066917A3 (en) | Use of asc as a marker for colorectal cancer | |
| WO2005040806A3 (en) | Use of protein asc as a marker for breast cancer | |
| WO2016100117A3 (en) | Accurate assay measurement of hydrophobic haptenic analytes | |
| EP2105741A3 (de) | Verwendung eines einen Bindungsteil exprimierenden Virus zur Messung von Analyten in einer Probe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |